Skip to content

Cancer Antigen 153 (CA 15-3) – Serum

Published: August 9, 2026Updated: August 17, 2026

This test measures the level of CA 15-3, a protein sometimes produced by certain types of cancer, including breast cancer and other malignancies.

Quick summary

["CA 15-3 helps monitor cancer progression or recurrence in some patients."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 17, 2026Editorial policy

Key facts at a glance

LOINC
50777-2
Short code
CA153PF
Synonyms
Cancer Ag15-3 Pcar-aCnc
Category
chemistry
Sample
serum
Container
Sterile, leak-proof container without additives (red-top or plain tube); specimen container appropriate for body fluids submitted for cytology and chemistry analysis.
Units
N/A
Ref low
15
Ref high
3
Critical range
0.5 N/A – —
Fasting
false
Population
adult
Sex
all
Age range
≥ 18 years
Method
Chemiluminescent Immunoassay (CLIA) or Electrochemiluminescence Immunoassay (ECLIA)
CPT
86300
SNOMED
115341000
Specimen volume
Minimum 1-2 mL of pericardial fluid; ideally 5-10 mL to allow for concurrent cytology and chemistry testing.
Stability
Refrigerated (2-8°C): 7 days; Frozen (-20°C or below): 30 days. Avoid repeated freeze-thaw cycles. Process promptly to prevent cellular degradation.
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
24–72 hours
Order
routine

What Is CA 15-3 Used For?

CA 15-3 is primarily used as a biomarker to track changes in cancer-related proteins, especially in patients who have already been diagnosed with breast cancer or other cancers that may produce this marker. It can also be used in screening or monitoring for certain conditions, though it is not a standalone diagnostic test for cancer.

How Is the Test Performed?

A blood sample is drawn from a vein in your arm. The blood is then sent to a lab for analysis using an immunoassay method to detect the CA 15-3 protein.

What Does a High or Low Level Mean?

Elevated levels of CA 15-3 may indicate cancer activity, but they can also be influenced by other factors such as pregnancy, obesity, or certain benign conditions. It is not a definitive test for cancer alone and should be interpreted by your healthcare provider in the context of your medical history and other test results.

When Might You Need This Test?

Your doctor may order a CA 15-3 test if you have breast cancer, are being monitored for recurrence, or if you have symptoms that could be linked to cancer. It may also be used in conjunction with other tests for screening or evaluating other conditions.

Reference range

No established reference range for pericardial fluid; CA 15-3 in pericardial fluid is not clinically standardized. Serum reference: <31.3 U/mL (varies by assay manufacturer). Elevated pericardial fluid levels relative to serum may suggest malignant pericardial effusion.N/A

Specimen: serum

No special patient preparation required for pericardial fluid collection, which is performed via pericardiocentesis by a qualified physician under sterile conditions.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: CA 15-3 plays a role in monitoring certain cancers, particularly breast cancer, but it is not a definitive diagnostic tool. High levels may suggest cancer progression or need for closer observation, while low levels may indicate remission. It is important to discuss results with your healthcare provider, as they will consider the full clinical picture.

Short name

CA 15-3 Blood Test

Frequently asked questions

Why might my CA 15-3 test result be abnormal?
Abnormal results could be due to cancer activity, but other factors like pregnancy, hormonal changes, or non-cancerous conditions may also affect levels. Your doctor will review the result with your overall health and test history.
Can CA 15-3 levels change over time?
Yes, CA 15-3 levels can fluctuate. They may rise if cancer grows or spreads and may fall if treatment is effective. Regular monitoring helps track these changes.
Is CA 15-3 the same as CA 125?
No, CA 15-3 and CA 125 are different markers. CA 15-3 is specific to certain cancers, while CA 125 is often used for ovarian cancer monitoring. Both are used in combination with other tests and clinical assessments.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 17, 2026. · Read our editorial policy